Basic Information
| LncRNA/CircRNA Name | UCA1 |
| Synonyms | UCA1, CUDR, LINC00178, NCRNA00178, UCAT1, onco-lncRNA-36 |
| Region | GRCh38_19:15828206-15836326 |
| Ensemble | ENSG00000214049 |
| Refseq | NR_015379 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hemangioma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | IH tissues,cell lines (EOMA and HemECs) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA UCA1 was up-regulated in proliferating-phase hemangioma samples, as compared to involuting-phase. |
| Pubmed ID | 30898646 |
| Year | 2019 |
| Title | Silence of long non-coding RNA UCA1 inhibits hemangioma cells growth, migration and invasion by up-regulation of miR-200c. |
External Links
| Links for UCA1 | GenBank HGNC NONCODE |
| Links for hemangioma | OMIM COSMIC |